Lack of toxicity of hydroethanolic extract from Mitragyna inermis (Willd.) O. Kuntze by gavage in the rat

Autor: J.F. Ikoli, F. Delmas, V. Chamlian, A.M. Lorec, G. Balansard, F. Traoré, H. Portugal, S. Monjanel-Mouterde, P. Pisano, F. Dodero, Monique Gasquet

Publikováno v: Journal of Ethnopharmacology. 103:319-326

In traditional medicine in Mali, extracts derived from Mitragyna inermis (Willd.) O. Kuntze (Family: Rubiaceae) are commonly used to treat malaria. The antimalarial activity and the lack of genotoxicity in vitro and in vivo have been demonstrated in

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::cdb5dd5abdda2ff41ce8571c7c4efa37
https://doi.org/10.1016/j.jep.2005.08.028

Pharmacokinetics of Tropatepine in Healthy Volunteers

Autor: C. Audebert, Alexandra Durand, J. P. Cano, H. Bun, S. Monjanel Mouterde, M. Vincent Du Laurier

Publikováno v: Clinical Drug Investigation. 14:53-60

Tropatepine is a compound with central anticholinergic properties that has been used in the treatment of neuroleptic-induced extrapyramidal syndrome. In this study, we report the plasma pharmacokinetics of tropatepine after intravenous and oral admin

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::a614641a8c1f9ac0c76f0d7dd2731766
https://doi.org/10.2165/00044011-199714010-00007

Severe acute toxicity associated with high-dose methotrexate (MTX) therapy: use of therapeutic drug monitoring and test-dose to guide carboxypeptidase G2 rescue and MTX continuation

Autor: J.-L. Bernard, Bruno Lacarelle, G. Galy, C. Coze, M.-A. Estève, S. Monjanel-Mouterde, Nicolas André, B. Devictor-Pierre

Publikováno v: European Journal of Clinical Pharmacology
European Journal of Clinical Pharmacology, 2006, 63 (1), pp.39-42. ⟨10.1007/s00228-006-0212-1⟩
European Journal of Clinical Pharmacology, Springer Verlag, 2006, 63 (1), pp.39-42. ⟨10.1007/s00228-006-0212-1⟩

International audience

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::721447797d74fd719c9f215c99da2ea1
https://hal.science/hal-01772507

Population pharmacokinetics of cisplatin after 120-h infusion: application to routine adaptive control with feedback

Autor: S, Monjanel-Mouterde, J, Ciccolini, D, Bagarry, M, Zonta-David, F, Duffaud, R, Favre, A, Durand

Publikováno v: Journal of clinical pharmacy and therapeutics. 28(2)

A Bayesian population pharmacokinetics study of data from routine therapeutic drug monitoring cisplatin during a 5-day infusion of cisplatin.A total of 95 kinetics data sets (58 patients) were available to perform this study. Individual pharmacokinet

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=pmid________::2392b062410e0d53db147505af60cba0
https://pubmed.ncbi.nlm.nih.gov/12713607

Bayesian calculation of methotrexate clearance after low dose intramuscular administration in patients with rheumatoid arthritis

Autor: S, Monjanel-Mouterde, P, Lafforgue, A, Blanc, J, Catalin, P C, Aquaviva, A, Durand

Publikováno v: The Journal of rheumatology. 25(7)

To determine a pharmacokinetic procedure (Bayesian method) for estimation of methotrexate (MTX) clearance, using only 2 blood samples, in outpatients with rheumatoid arthritis treated with low dose intramuscular (i.m.) MTX.Population pharmacokinetic

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=pmid________::57037bf9bce6548308f534f0c116116a
https://pubmed.ncbi.nlm.nih.gov/9676756